Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Advances in stem cell research

Advances in stem cell research

Detailed diagnosis boosts child cancer survival

Detailed diagnosis boosts child cancer survival

Cultured stem cells and bioengineered skin used to successfully treat scleroderma

Cultured stem cells and bioengineered skin used to successfully treat scleroderma

Better understanding of how stem cells develop into blood cells

Better understanding of how stem cells develop into blood cells

European Commission and US FDA approve intravenous formulation of temozolomide

European Commission and US FDA approve intravenous formulation of temozolomide

New study using combination of bioengineered skin and stem cells shows promise in treatment of non-healing wounds

New study using combination of bioengineered skin and stem cells shows promise in treatment of non-healing wounds

FDA provides positive review of InNexus' lead preclinical drug candidate

FDA provides positive review of InNexus' lead preclinical drug candidate

Study examines maternal and newborn health risks and colorectal cancer

Study examines maternal and newborn health risks and colorectal cancer

B-cell clones as early markers for chronic lymphocytic leukemia

B-cell clones as early markers for chronic lymphocytic leukemia

Cancer Research UK launches first super cancer centre in Birmingham

Cancer Research UK launches first super cancer centre in Birmingham

New understanding on how Myc gene promotes cancer

New understanding on how Myc gene promotes cancer

New device decreases wait times for patients needing immunotherapy

New device decreases wait times for patients needing immunotherapy

Molecular machine turns packaged messenger RNA into a linear transcript

Molecular machine turns packaged messenger RNA into a linear transcript

Bone marrow transplant patients may benefit from new immune research

Bone marrow transplant patients may benefit from new immune research

New understanding of how leukemia develops

New understanding of how leukemia develops

New genes involved in acute lymphoblastic leukemia play fundamental role in prognosis of the disease

New genes involved in acute lymphoblastic leukemia play fundamental role in prognosis of the disease

Sangamo BioSciences starts trial of CCR5-ZFP therapeutic to treat HIV/AIDS

Sangamo BioSciences starts trial of CCR5-ZFP therapeutic to treat HIV/AIDS

Research to provide information of long-term effects of childhood cancer treatment to parents

Research to provide information of long-term effects of childhood cancer treatment to parents

End-of-life care at hospitals varies for children with cancer

End-of-life care at hospitals varies for children with cancer

Green tea may counteract anticancer effects of cancer therapy, bortezomib (Velcade)

Green tea may counteract anticancer effects of cancer therapy, bortezomib (Velcade)

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.